How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

QU

NASDAQ:QURE
Get a brief AI stock analysisSaves ~ 15 minutes of your time

QU

Uniqure NVNASDAQ QURE Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is QURE undervalued compared to its fair value?

The fair value of QURE stock is hidden USD. Relative to the market price of 7.74 USD Uniqure NV is hidden.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. The company is headquartered in Amsterdam, Noord-Holland and currently employs 501 full-time employees. The company we...[More about valuation]

Uniqure NV Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.379 $B

Price:

7.74 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-1.356

FINANCIALS

Uniqure NV financial for reporting period

Income Statement

0.0085 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.054 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.066 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0.0085 B 100%
-0.0007 B -9%
-0.054 B -639%
-0.066 B -773%

Balance Sheet

0.77 B
0.15 B


Financial Position Analysis

Assets

0.77 B
Current Assets
0.6 B
Total non-current assets
0.17 B

Total current liabilities
0.063 B
Total non-current liabilities
0.56 B

Cash Flow Statement

-0.063 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.061 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Uniqure NV fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators

-122 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-154 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-35 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is QURE attractive for investment based on fundamental analysis?

QURE stock rating is hidden. Uniqure NV is a hidden by Eyestock methodology.

Get QURE Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

-1 564

Gross Margin:

-7

CFO / Debt ratio:

hidden

Current ratio:

9.843

Debt / Equity ratio:

2.009

ROE:

-122

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

QURE analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for QURE to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Uniqure NV competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

Uniqure NV dividends

QURE dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About QURE stock

About the company Uniqure NV

Market cap $B

0.379

Dividend yield

Shares outstanding

46.9825 B

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. The company is headquartered in Amsterdam, Noord-Holland and currently employs 501 full-time employees. The company went IPO on 2014-02-05. The company seeks to develop one-time administered treatments with potentially curative results for patients suffering from genetic and other devastating diseases. The company develops, both internally and through partnerships, a pipeline of gene therapies. The company produces adeno-associated virus based, or AAV-based, gene therapies in its own facilities with a proprietary, commercial-scale, current good manufacturing practices, compliant, manufacturing process. AMT-061, the Company’s lead product candidate for patients with hemophilia B, is going through a dosing phase of a pivotal study. AMT-130, the product candidate for patients with Huntington’s disease is in Phase I/II clinical study.

QURE profile

  • Ticker

    QURE

  • Country

    Netherlands

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    05 February 2014

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    501

  • City

    Amsterdam

  • Address

    Paasheuvelweg 25a

  • Cusip

    N90064101